183 related articles for article (PubMed ID: 38540734)
1. Identification and Validation of a PEX5-Dependent Signature for Prognostic Prediction in Glioma.
Qin X; Wang B; Lu X; Song Y; Wang W
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540734
[TBL] [Abstract][Full Text] [Related]
2. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
[TBL] [Abstract][Full Text] [Related]
3. A missense allele of PEX5 is responsible for the defective import of PTS2 cargo proteins into peroxisomes.
Ali M; Khan SY; Rodrigues TA; Francisco T; Jiao X; Qi H; Kabir F; Irum B; Rauf B; Khan AA; Mehmood A; Naeem MA; Assir MZ; Ali MH; Shahzad M; Abu-Amero KK; Akram SJ; Akram J; Riazuddin S; Riazuddin S; Robinson ML; Baes M; Azevedo JE; Hejtmancik JF; Riazuddin SA
Hum Genet; 2021 Apr; 140(4):649-666. PubMed ID: 33389129
[TBL] [Abstract][Full Text] [Related]
4. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY
J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193
[TBL] [Abstract][Full Text] [Related]
5. The peroxisomal import receptor PEX5 functions as a stress sensor, retaining catalase in the cytosol in times of oxidative stress.
Walton PA; Brees C; Lismont C; Apanasets O; Fransen M
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1833-1843. PubMed ID: 28760655
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Karsy M; Guan J; Huang LE
J Neurosurg; 2018 Mar; 130(1):56-66. PubMed ID: 29547090
[TBL] [Abstract][Full Text] [Related]
7. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
Chen SC; Lo CM; Wang SH; Su EC
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
[TBL] [Abstract][Full Text] [Related]
8. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
[TBL] [Abstract][Full Text] [Related]
9. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
10. A
Gonzalez KL; Ratzel SE; Burks KH; Danan CH; Wages JM; Zolman BK; Bartel B
Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3163-E3172. PubMed ID: 29555730
[TBL] [Abstract][Full Text] [Related]
11. PEX5 translocation into and out of peroxisomes drives matrix protein import.
Skowyra ML; Rapoport TA
Mol Cell; 2022 Sep; 82(17):3209-3225.e7. PubMed ID: 35931083
[TBL] [Abstract][Full Text] [Related]
12. The Arabidopsis peroxisomal targeting signal type 2 receptor PEX7 is necessary for peroxisome function and dependent on PEX5.
Woodward AW; Bartel B
Mol Biol Cell; 2005 Feb; 16(2):573-83. PubMed ID: 15548601
[TBL] [Abstract][Full Text] [Related]
13. PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import.
Chang CC; Warren DS; Sacksteder KA; Gould SJ
J Cell Biol; 1999 Nov; 147(4):761-74. PubMed ID: 10562279
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.
Ducray F; Mokhtari K; Crinière E; Idbaih A; Marie Y; Dehais C; Paris S; Carpentier C; Dieme MJ; Adam C; Hoang-Xuan K; Duyckaerts C; Delattre JY; Sanson M
Eur J Cancer; 2011 Mar; 47(5):802-8. PubMed ID: 21194923
[TBL] [Abstract][Full Text] [Related]
15. Identification of an epigenetic prognostic signature for patients with lower-grade gliomas.
Yu H; Zhang D; Lian M
CNS Neurosci Ther; 2021 Apr; 27(4):470-483. PubMed ID: 33459509
[TBL] [Abstract][Full Text] [Related]
16. A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.
Xu J; Liu F; Li Y; Shen L
Cell Mol Neurobiol; 2022 Apr; 42(3):709-722. PubMed ID: 32894375
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system.
Figarella-Branger D; Bouvier C; de Paula AM; Mokhtari K; Colin C; Loundou A; Chinot O; Metellus P
J Neurooncol; 2012 Nov; 110(2):205-13. PubMed ID: 22890969
[TBL] [Abstract][Full Text] [Related]
18. Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
Hu X; Martinez-Ledesma E; Zheng S; Kim H; Barthel F; Jiang T; Hess KR; Verhaak RGW
Neuro Oncol; 2017 Jun; 19(6):786-795. PubMed ID: 28340142
[TBL] [Abstract][Full Text] [Related]
19. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
20. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
Chen J; Li Y; Han X; Pan Y; Qian X
Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
